Atomo NewsGet the app

Get the latest Science News and Discoveries

RECOVER-VITAL clinical trial finds no benefit of extended duration of PAXLOVID for Long COVID


Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of Long Covid

Long Covid

Photo of Paxlovid

Paxlovid

Photo of benefit

benefit

Related news:

News photo

When do infections lead to long COVID? Scientists close in on triggers and treatments for post-viral syndromes

News photo

No demonstration of benefit with hydralazine plus isosorbide dinitrate in heart failure

News photo

RECOVER-VITAL clinical trial finds no benefit of extended duration of PAXLOVID for Long COVID

« Construction of one-dimensional ultra heat-resistant perovskite energetic material via dimethyl passivation of labile N–H bonds
A bright space station will soar over the US this week — and it's not the ISS. Here's how to see it »